1. Overcome tumor relapse in CAR T cell therapy

   • Cheng-Dong Huo
   • Jie Yang
   • Yu-Min Li

   Review Article 09 June 2022 Pages: 1833 - 1843

   

2. Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis

   • Chandra Prakash Prasad
   • Ajay Gogia
   • Atul Batra

   Review Article 25 June 2022 Pages: 1844 - 1855

   

3. CDC7 as a novel biomarker and druggable target in cancer

   • Runze Liu
   • Yong Huang

   Review Article 03 June 2022 Pages: 1856 - 1864

   

4. Glycosylation and its research progress in endometrial cancer

   • Congli Pu
   • Biyuan
   • Yingchao Zhao

   Review Article Open access 25 June 2022 Pages: 1865 - 1880

   

5. The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target

   • Somayeh Vafaei
   • Hamed Taheri
   • Firoozeh Abolhasani Zadeh

   Review Article 10 June 2022 Pages: 1881 - 1889

   

6. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

   • José Trigo
   • Mónica García-Cosío
   • Margarita Alberola-Ferranti

   Special Article Open access 23 June 2022 Pages: 1890 - 1902

   

7. Diagnostic impact of ¹⁸F-FDG PET/CT imaging on the detection of immune-related adverse events in patients treated with immunotherapy

   • Gamze Tatar
   • Göksel Alçin
   • Tevfik Fikret Cermik

   Research Article 20 May 2022 Pages: 1903 - 1913

   

8. Effect of PPP1R14D gene high expression in lung adenocarcinoma knocked out on proliferation and apoptosis of DMS53 cell

   • Ye Tian
   • Liguo Guan
   • Zexin Gu

   Research Article 17 May 2022 Pages: 1914 - 1923

   

9. Cell-free circulating tumor DNA in colorectal cancer: a proof of concept with simplified methodology

   • Javier Bosque
   • Carlos Guirao
   • Javier Gallego Plazas

   Research Article 02 May 2022 Pages: 1924 - 1931

10. Spinal cord compression of neoplastic origin: surgical experience using a common clinical language

    • Oscar Godino
    • Ignacio Visus
    • Arturo Navarro-Martin

    Research Article 02 June 2022 Pages: 1932 - 1939

    

11. MiR-6511b-5p suppresses metastasis of pMMR colorectal cancer through methylation of CD44 by directly targeting BRG1

    • JinMing Sun
    • Ling Ye
    • BingYu Qin

    Research Article Open access 19 May 2022 Pages: 1940 - 1953

    

12. FOXD2-AS1 acts an oncogene in esophageal squamous cell carcinoma through sponging miR-204-3p

    • Dongbo Luo
    • Adili Salai
    • Yunfei Gao

    Research Article 01 July 2022 Pages: 1954 - 1963

    

13. FJX1 as a candidate diagnostic and prognostic serum biomarker for colorectal cancer

    • Lei Liu
    • Yecai Huang
    • Yuanbiao Guo

    Research Article 01 June 2022 Pages: 1964 - 1974

    

14. Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors

    • Chang Liu
    • Zhenxing Wang
    • Shaofeng Duan

    Research Article 06 June 2022 Pages: 1975 - 1985

    

15. Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer

    • Junqun Liao
    • Yuan Ye
    • Xuren Xu

    Research Article 23 June 2022 Pages: 1986 - 1997

    

16. HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC

    • Xiaoyan Wang
    • Yun Zhou
    • Huiqin Quan

    Research Article 29 June 2022 Pages: 1998 - 2009

    

17. Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group

    • Manuel Sánchez Cánovas
    • David Fernández Garay
    • Andrés Jesús Muñoz Martín

    Research Article Open access 06 June 2022 Pages: 2010 - 2020

    

18. MiR-507 inhibits the progression of gastric carcinoma via targeting CBX4-mediated activation of Wnt/β-catenin and HIF-1α pathways

    • Xin Fang
    • Anping Pan

    Research Article 11 July 2022 Pages: 2021 - 2028

    

19. Tumor-infiltrating OX40⁺ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma

    • Qiwei Zhang
    • Weiwei Rui
    • Xiaoyi Ding

    Research Article 22 June 2022 Pages: 2029 - 2038

    

20. Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience

    • Giulio Francolini
    • Riccardo Campi
    • Lorenzo Livi

    Brief Research Article Open access 23 June 2022 Pages: 2039 - 2043

    

21. Correction to: Emerging roles of JMJD3 in cancer

    • Maryam Farzaneh
    • Zeinab Kuchaki
    • Omid Anbiyaee

    Correction 05 July 2022 Pages: 2044 - 2044